In AML, mutations of this RTK are predominantly found with either t(8;21) or inv(16) chromosomal rearrangements, leading to the fusion proteins RUNX1-RUNX1T1 and CBFB-MYH11, respectively, referred to as core binding factor (CBF) AML. Here, RUNX1 is linked to acute myeloid leukemia.